article thumbnail

World's largest proteomics trial launched by UK Biobank

pharmaphorum

A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today.

article thumbnail

J&J’s Christopher Whelan on How—and Why—13 Companies Teamed up to Tackle Proteomics

BioSpace

The Pharma Proteomics Project isn’t the first precompetitive collaboration between pharma companies, but it’s one of the largest. Members recently published associations they’ve uncovered in UK Biobank data.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digitalising drug discovery

pharmaphorum

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. .

article thumbnail

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

As part of the US government’s Cancer Moonshot initiative, a Cancer Moonshot Biobank was launched that asked participants to donate biospecimens and associated health information to aid research. The focus of research projects on gathering data, particularly genetic data, is now common place in nationwide health-focused initiatives.